GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Auxly Cannabis Group Inc (OTCPK:CBWTF) » Definitions » Research & Development

CBWTF (Auxly Cannabis Group) Research & Development : $0.20 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Auxly Cannabis Group Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Auxly Cannabis Group's Research & Development for the three months ended in Dec. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was $0.20 Mil.

Auxly Cannabis Group Research & Development Historical Data

The historical data trend for Auxly Cannabis Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Auxly Cannabis Group Research & Development Chart

Auxly Cannabis Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.23 0.22 0.37 -

Auxly Cannabis Group Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.10 0.02 0.08 -

Auxly Cannabis Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Auxly Cannabis Group  (OTCPK:CBWTF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Auxly Cannabis Group Research & Development Related Terms

Thank you for viewing the detailed overview of Auxly Cannabis Group's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Auxly Cannabis Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Auxly Cannabis Group Inc (OTCPK:CBWTF) » Definitions » Research & Development
Comparable Companies
XCNQ:AAWH.U TSXV:RX TSX:CRDL TSXV:LOVE TSXV:SBBC XCNQ:JUSH XCNQ:PLTH TSX:MDP TSX:HLS TSX:TSND ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
3KF:Germany XLY:Canada
Address
777 Richmond Street West, Unit 002, Toronto, ON, CAN, M6J 0C2
Website
https://www.auxly.com
Auxly Cannabis Group Inc is a consumer-packaged-goods company in the cannabis products market. The company has created a portfolio of brands designed for a broad market of cannabis consumers, with differentiation in price points across targeted consumer segments. Its product portfolio comprises dried cannabis, fresh cannabis, cannabis plants, cannabis seeds, cannabis oil, edible cannabis, cannabis extracts, and cannabis topicals, among others, which are marketed through brands like Parcel, Black Forty, Foray, Dosecann, and Kolab Project. The company operates through two operating segments: Canadian cannabis operations, which generate all of the revenue, and South American cannabis operations.